<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02050672</url>
  </required_header>
  <id_info>
    <org_study_id>MI_ICSI</org_study_id>
    <nct_id>NCT02050672</nct_id>
  </id_info>
  <brief_title>Effect of Myoinositol Treatment of Spermatozoa on in Vitro Fertilization Outcome</brief_title>
  <acronym>MI_ICSI</acronym>
  <official_title>Effect of Myoinositol Treatment of Spermatozoa on in Vitro Fertilization Outcome: a Prospective, Randomized Sibling-oocyte Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AGUNCO Obstetrics and Gynecology Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AGUNCO Obstetrics and Gynecology Centre</source>
  <brief_summary>
    <textblock>
      In the present trial, the investigators aim to evaluate whether semen myo-inositol (MI)&#xD;
      treatment is able to improve IVF outcomes.&#xD;
&#xD;
      In particular, retrieved oocytes will be randomly divided in two groups, one group will be&#xD;
      inseminated with MI treated semen while the other will be inseminated with untreated semen.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Myo is synthesized from glucose-6-phosphate, it is a precursor of second messengers in the&#xD;
      cell signaling pathways and it is involved in the regulation of intracellular calcium.&#xD;
&#xD;
      Literature data have demonstrated the MI play a crucial role in reproduction, indeed, oocyte&#xD;
      and spematozoa are nursed in a medium congaing hig MI concentration.&#xD;
&#xD;
      Furthermore, it has been demonstrated that, in oligoasthenoteratozoospermic patients, in&#xD;
      vitro incubation with 2 mg/ml of myo increase significantly the number of spermatozoa with&#xD;
      high mitochondrial membrane potential (MMP). Moreover, it has been found that the in vitro&#xD;
      fertilization rate is correlated with the percentage of high MMP spermatozoa.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Actual">July 2021</completion_date>
  <primary_completion_date type="Actual">January 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fetilization rate</measure>
    <time_frame>Day 1</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Embryo quality</measure>
    <time_frame>Day 2 to Day 5</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">249</enrollment>
  <condition>Couple Sterility</condition>
  <arm_group>
    <arm_group_label>untreated</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Semen was prepared with routinely used media</description>
  </arm_group>
  <arm_group>
    <arm_group_label>myo-inositol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>routinely used semen preparation media have been enriched with myo-inositol 2mg/ml.&#xD;
in particular the stock solution was prepared in order to add 15microliters per ml of medium</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Myo-inositol</intervention_name>
    <arm_group_label>myo-inositol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>untreated</intervention_name>
    <arm_group_label>untreated</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  couple counselled for IVF&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  cryopreserved sample&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>42 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>TECNOLAB</name>
      <address>
        <city>Milan</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Condorelli RA, La Vignera S, Bellanca S, Vicari E, Calogero AE. Myoinositol: does it improve sperm mitochondrial function and sperm motility? Urology. 2012 Jun;79(6):1290-5. doi: 10.1016/j.urology.2012.03.005.</citation>
    <PMID>22656408</PMID>
  </reference>
  <reference>
    <citation>Nomikos M, Swann K, Lai FA. Starting a new life: sperm PLC-zeta mobilizes the Ca2+ signal that induces egg activation and embryo development: an essential phospholipase C with implications for male infertility. Bioessays. 2012 Feb;34(2):126-34. doi: 10.1002/bies.201100127. Epub 2011 Nov 16. Review.</citation>
    <PMID>22086556</PMID>
  </reference>
  <reference>
    <citation>Condorelli RA, La Vignera S, Di Bari F, Unfer V, Calogero AE. Effects of myoinositol on sperm mitochondrial function in-vitro. Eur Rev Med Pharmacol Sci. 2011 Feb;15(2):129-34.</citation>
    <PMID>21434479</PMID>
  </reference>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>January 27, 2014</study_first_submitted>
  <study_first_submitted_qc>January 29, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 31, 2014</study_first_posted>
  <last_update_submitted>July 30, 2021</last_update_submitted>
  <last_update_submitted_qc>July 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Myoinositol</keyword>
  <keyword>ART</keyword>
  <keyword>EMBRYO QUALITY</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inositol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

